Research Summary

Dr. Scarlett Lin Gomez is an epidemiologist with research interests in the role of social determinants of health, including race/ethnicity, socioeconomic status, gender, immigration status, sociocultural factors, and neighborhood contextual characteristics, on health outcomes. She is also Director of the Greater Bay Area Cancer Registry, a part of the California Cancer Registry and the NCI Surveillance Epidemiology End Results (SEER) Program. She has contributed surveillance data regarding cancer incidence and outcome patterns and trends for distinct Asian American, Native Hawaiian, and Pacific Islander and Hispanic ethnic groups, as well as cancer patterns by nativity status and neighborhood characteristics. She developed the California Neighborhoods Data System, a compilation of small-area level data on social and built environment characteristics, and has used these data in more than a dozen funded studies to evaluate the impact of social and built neighborhood environment factors on disease outcomes.

Research Funding

  • July 1, 2020 - June 30, 2025 - Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach, Co-Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: R01CA243188
  • June 8, 2020 - May 31, 2025 - Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes, Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: R01CA241125
  • February 1, 2020 - November 30, 2024 - Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers, Principal Investigator. Sponsor: NIH/NIMHD, Sponsor Award ID: R01MD014859
  • June 10, 2019 - May 31, 2024 - Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE), Co-Principal Investigator. Sponsor: NIH/NCI, Sponsor Award ID: R01CA241128

Education

University of California, Berkeley, CA B.A. 06/94 Biochemistry and Molecular Biology
University of Michigan, Ann Arbor, MI M.P.H. 06/97 Epidemiology
Stanford University, Stanford, CA Ph.D. 12/02 Epidemiology

Honors & Awards

  • 2022
    ASPO Joseph F. Fraumeni, Jr., Distinguished Achievement Award
  • 2014
    Mentoring Award, Cancer Prevention Institute of California
  • 2012
    Above and Beyond Excellence Award, Cancer Prevention Institute of California
  • 2010
    Author of the Year, American Journal of Public Health
  • 2007
    Selected participant, NCI Minority Investigators Workshop on Behavioral Methodologies
  • 1998-2002
    Pre-Doctoral Cancer Training Grant, NCI (awarded to Stanford University, Stanford, CA)
  • 2000
    Scholarship, 7th Biennial Symposium on Minorities, the Medically Underserved & Cancer
  • 1997
    Student Oncology Grant, American Cancer Society, California Division, Oakland, CA
  • 1996-1997
    Departmental Scholarship, School of Public Health, University of Michigan, Ann Arbor, MI

Selected Publications

  1. Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update. Cancer Epidemiol Biomarkers Prev. 2021 Nov 30.  View on PubMed
  2. Press DJ, Shariff-Marco S, Lichtensztajn DY, Lauderdale D, Murphy AB, Inamdar PP, DeRouen MC, Hamilton AS, Yang J, Lin K, Hedeker D, Haiman CA, Cheng I, Gomez SL. Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California. Cancer Epidemiol Biomarkers Prev. 2021 Nov 30.  View on PubMed
  3. Clarke CA, Patel AV, Kurian AW, Hubbell E, Gomez SL. Racial/ethnic differences in cancer diagnosed after metastasis: absolute burden and deaths potentially avoidable through earlier detection. Cancer Epidemiol Biomarkers Prev. 2021 Nov 22.  View on PubMed
  4. Chu JN, Canchola AJ, Keegan THM, Nickell A, Oakley-Girvan I, Hamilton AS, Yu RL, Gomez SL, Shariff-Marco S. Evaluating the Impact of Social and Built Environments on Health-Related Quality of Life among Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2021 Nov 02.  View on PubMed
  5. Gomez SL, Patierno SR. Toward Achieving Health Equity - ASPO's 2022 Annual Meeting March 13-15, 2022 Marriott University Park, Tucson, Arizona. Cancer Epidemiol Biomarkers Prev. 2021 Nov; 30(11):2140.  View on PubMed
  6. Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer Prostatic Dis. 2021 Sep 10.  View on PubMed
  7. Aoki RF, Uong SP, Gomez SL, Alexeeff SE, Caan BJ, Kushi LH, Torres JM, Guan A, Canchola AJ, Morey BN, Lin K, Kroenke CH. Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California. Cancer. 2021 Aug 20.  View on PubMed
  8. Kurian AW, Abrahamse P, Bondarenko I, Hamilton AS, Deapen D, Gomez SL, Morrow M, Berek JS, Hofer TP, Katz SJ, Ward KC. Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer. J Natl Cancer Inst. 2021 Aug 09.  View on PubMed
  9. DeRouen MC, Canchola AJ, Thompson CA, Jin A, Nie S, Wong C, Lichtensztajn D, Allen L, Patel MI, Daida YG, Luft HS, Shariff-Marco S, Reynolds P, Wakelee HA, Liang SY, Waitzfelder BE, Cheng I, Gomez SL. Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females. J Natl Cancer Inst. 2021 Aug 04.  View on PubMed
  10. DeRouen MC, Yang J, Jain J, Weden MM, Gomez SL, Shariff-Marco S. Disparities in Prostate Cancer Survival According to Neighborhood Archetypes, A Population-Based Study. Urology. 2021 Jul 22.  View on PubMed
  11. Dee EC, Chen S, Santos PMG, Wu SZ, Cheng I, Gomez SL. Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research. Cancer Epidemiol Biomarkers Prev. 2021 08; 30(8):1455-1458.  View on PubMed
  12. DeRouen MC, Thompson CA, Canchola AJ, Jin A, Nie S, Wong C, Jain J, Lichtensztajn DY, Li Y, Allen L, Patel MI, Daida YG, Luft HS, Shariff-Marco S, Reynolds P, Wakelee HA, Liang SY, Waitzfelder BE, Cheng I, Gomez SL. Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups. Cancer Epidemiol Biomarkers Prev. 2021 Aug; 30(8):1506-1516.  View on PubMed
  13. Morey BN, Gee GC, Wang MC, von Ehrenstein OS, Shariff-Marco S, Canchola AJ, Yang J, Lee SS, Bautista R, Tseng W, Chang P, Gomez SL. Neighborhood Contexts and Breast Cancer Among Asian American Women. J Immigr Minor Health. 2021 Apr 12.  View on PubMed
  14. Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. J Urol. 2021 07; 206(1):171-172.  View on PubMed
  15. Iyer HS, Gomez SL, Chen JT, Trinh QD, Rebbeck TR. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position. Cancer. 2021 Jul 15; 127(14):2525-2534.  View on PubMed
  16. Shariff-Marco S, DeRouen MC, Yang J, Jain J, Nelson DO, Weden MM, Gomez SL. Neighborhood archetypes and breast cancer survival in California. Ann Epidemiol. 2021 05; 57:22-29.  View on PubMed
  17. Borno HT, Duffy C, Zhang S, Canchola AJ, Loya Z, Golden T, Oh DL, Odisho AY, Gomez S. Integration of electronic pathology reporting with clinical trial matching for advanced prostate cancer. Urol Oncol. 2021 08; 39(8):494.e7-494.e14.  View on PubMed
  18. John EM, McGuire V, Kurian AW, Koo J, Shariff-Marco S, Gomez SL, Cheng I, Keegan THM, Kwan ML, Bernstein L, Vigen C, Wu AH. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev. 2021 02; 30(2):351-363.  View on PubMed
  19. Borno HT, Idossa D, Gomez SL. Policy and Health: Leveraging a Social Determinants of Health Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer. JCO Oncol Pract. 2021 03; 17(3):121-124.  View on PubMed
  20. Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. JAMA Netw Open. 2020 12 01; 3(12):e2031349.  View on PubMed

Go to UCSF Profiles, powered by CTSI